Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Clin Pharmacol Ther. 2017 Apr 6;102(2):213–218. doi: 10.1002/cpt.598

TABLE 1.

ASSIGNMENT OF LIKELY CYP2D6 PHENOTYPES BASED ON DIPLOTYPES

Likely phenotype Activity
Score
Genotypesa Examples of CYP2D6 diplotypes
CYP2D6 ultrarapid
metabolizer
(~1–2% of patients)b
> 2.0 An individual carrying duplications of
functional alleles
*1/*1xN, *1/*2xN, *2/*2xNc
CYP2D6 normal
metabolizer
(~77–92% of patients)
2.0-1.0d An individual carrying two normal
function alleles or two decreased
function alleles or one normal function
and one no function allele or one
normal function and one decreased
function allele or combinations of
duplicated alleles that result in an
activity score of 1.0 –2.0.
*1/*1, *1/*2, *1/*4, *1/*5, *1/*9, *1/*41,
*2/*2,*41/*41
CYP2D6 intermediate
metabolizer
(~2–11% of patients)
0.5 An individual carrying one decreased
function and one no function allele
*4/*10,*4/*41, *5/*9
CYP2D6 poor
metabolizer
(~5–10% of patients)
0 An individual carrying only no
functional alleles
*3/*4,*4/*4, *5/*5, *5/*6
a

Assignment of allele function and citations for allele function can be found https://www.pharmgkb.org/page/cyp2d6RefMaterials (CYP2D6 Allele Definition Table and CYP2D6 Allele Functionality References Table (1)).

b

See the CYP2D6 Frequency Table (1) for race-specific allele and phenotype frequencies or see Gaedigk et al (30).

c

WherexN represents the number of CYP2D6 gene copies. For individuals with CYP2D6 duplications or multiplications, see supplemental data for additional information on how to translate diplotypes into phenotypes.

d

Patients with an activity score of 1.0 may be classified as intermediate metabolizers by some reference laboratories.